For perspective, the average R&D cost per successful drug is somewhere well into the billions:<p><a href="http://www.forbes.com/sites/matthewherper/2012/02/10/the-truly-staggering-cost-of-inventing-new-drugs/" rel="nofollow">http://www.forbes.com/sites/matthewherper/2012/02/10/the-tru...</a><p>Not sure what the idea is here. Going by cold statistics, this will cost orders of magnitude more than they are seeking from crowd funding. And even then, with overwhelming likelihood, it will fail in clinical trials.
For anyone else wondering on what types of cancer this might work on, from [1]:<p>Q: Which cancers will 9DS work on?<p>A: We don't have a definitive answer, but initial tests show that it's strongest against some forms of renal (kidney) cancer, melanoma(skin) cancer, and triple-negative breast cancer. We have reason to believe that variants of 9DS will target different cancer types, as well.<p>[1]: <a href="http://www.indysci.org/details.html" rel="nofollow">http://www.indysci.org/details.html</a> "Details"
When you say "open notebook" does that mean outside people can see your results and contribute intellectually to the project? Is there a synthetic route to 9DS? I didn't see much on a quick google search but it doesn't look like a terribly difficult molecule to make.
What about drug resistance? Any data available/planned in that regard?<p>Curious about it, because I work on this stuff from a structural perspective as my profession.